Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 59, Issue 3, 2005, Pages 375-388

  Bilati, Ugo ^a   Allémann, Eric ^a,b   Doelker, Eric ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Bracco Suisse SA   (Switzerland)

Author keywords

Biodegradable polymers; Microparticles; Nanoparticles; Peptides; PLA; PLGA; Proteins; Stabilization

Indexed keywords

ASPARAGINASE; CALCITONIN; CARBONATE DEHYDRATASE; CHYMOTRYPSIN; CYTOKINE; DIPHTHERIA ANTIBODY; ERYTHROPOIETIN; ESCHERICHIA COLI ENTEROTOXIN; GLUCOSE OXIDASE; GROWTH HORMONE; HEPARIN LYASE; HEPATITIS B CORE ANTIGEN; HORSERADISH PEROXIDASE; INSULIN; INTERFERON; LEUPRORELIN; LYSOZYME; NAFARELIN; NANOPARTICLE; PARATHYROID HORMONE; POLYGLACTIN; PROTEIN; PROTEIN C; SOMATOMEDIN C; STAPHYLOCOCCUS ENTEROTOXIN; SUPEROXIDE DISMUTASE; TETANUS TOXOID; TETRACOSACTIDE; TRYPSIN; TUMOR NECROSIS FACTOR; UREASE;

BIODEGRADABILITY; DRUG RELEASE; ENCAPSULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROTEIN ANALYSIS; REVIEW;

EID: 14844317382     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.10.006     Document Type: Review

References (121)

1. G.C. Davis Protein stability: impact upon protein pharmaceuticals Biologicals 21 1993 105
2. A.J.S. Jones, and J.L. Cleland Technical and regulatory hurdles in delivery aspects of macromolecular drugs J. Control. Release 41 1996 147 155
3. C.H. Niu, and Y.Y. Chiu FDA perspective on peptide formulation and stability issues J. Pharm. Sci. 87 1998 1331 1334
4. P. Johansen, Y. Men, H.P. Merkle, and B. Gander Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination Eur. J. Pharm. Biopharm. 50 2000 129 146
5. M. Wolf, M. Wirth, F. Pittner, and F. Gabor Stabilisation and determination of the biological activity of l-asparaginase in poly(d,l-lactide-co-glycolide) nanospheres Int. J. Pharm. 256 2003 141 152
6. C. Witschi, Residual solvents and degradation of a peptide drug and of poly(alpha-hydroxy acids) in microparticles prepared by different methods, PhD Thesis, 1997.
7. J.C. Ryff, and H. Schellenks Immunogenicity of rDNA-derived pharmaceuticals Trends Pharmacol. Sci. 23 2002 254 256
8. M.F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron Protein C-loaded monomethoxypoly(ethylene oxide)-poly(lactic acid) nanoparticles Int. J. Pharm. 212 2001 1 9
9. M.P. Desai, J.M. Hilfinger, G.L. Amidon, R.J. Levy, and V. Labhasetwar Immune response with biodegradable nanospheres and alum: studies in rabbits using staphylococcal enterotoxin B-toxoid J. Microencapsul. 17 2000 215 225
10. L. Chen, R.N. Apte, and S. Cohen Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy J. Control. Release 43 1997 261 272
11. J.L. Cleland, A. Daugherty, and R. Mrsny Emerging protein delivery methods Curr. Opin. Biotechnol. 12 2001 212 219
12. T. Uchida, K. Shiosaki, Y. Nakada, K. Fukada, Y. Eda, S. Tokiyoshi, N. Nagareya, and K. Matsuyama Microencapsulation of hepatitis B core antigen for vaccine preparation Pharm. Res. 15 1998 1708 1713
13. W. Lu, and T.G. Park Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems, PDA J. Pharm. Sci. Technol. 49 1995 13 19
14. R.S. Raghuvanshi, S. Goyal, O. Singh, and A.K. Panda Stabilization of dichloromethane-induced protein denaturation during microencapsulation Pharm. Dev. Technol. 3 1998 269 276
15. T.G. Park, W. Lu, and G. Crotts Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(d,l-lactic acid-co-glycolic acid) microspheres J. Control. Release 33 1995 211 222
16. G. Crotts, and T.G. Park Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues J. Microencapsul. 15 1998 699 713
17. W. Wang Instability, stabilization, and formulation of liquid protein pharmaceuticals Int. J. Pharm. 185 1999 129 188
18. M.C. Manning, K. Patel, and R.T. Borchardt Stability of protein pharmaceuticals Pharm. Res. 6 1989 903 918
19. D. Wong, and J. Parasrampuria Pharmaceutical excipients for the stabilization of proteins Pharm. Technol. 21 10 1997 34 50
20. M. van de Weert, W.E. Hennink, and W. Jiskoot Protein instability in poly(lactic-co-glycolic acid) microparticles Pharm. Res. 17 2000 1159 1167
21. S.P. Schwendeman Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems Crit. Rev. Ther. Drug Carrier Syst. 19 2002 73 98
22. M.C. Lai, and E.M. Topp Solid-state chemical stability of proteins and peptides J. Pharm. Sci. 88 1999 489 500
23. B.B.C. Youan, J. Gillard, and B. Rollmann Protein-loaded poly(ε-caprolactone) microparticles. III. Entrapment of superoxide dismutase by the (water-in-oil)-in water solvent evaporation method STP Pharm. Sci. 9 1999 175 181
24. X. Li, Y. Zhang, R. Yan, W. Jia, M. Yuan, X. Deng, and Z. Huang Influence of process parameters on the protein stability encapsulated in poly-dl-lactide-poly(ethylene glycol) microspheres J. Control. Release 68 2000 41 52
25. W. Jiang, and S.P. Schwendeman Stabilization and controlled release of bovine serum albumin encapsulated in poly(d,l-lactide) and poly(ethylene glycol) microsphere blends Pharm. Res. 18 2001 878 885
26. H. Takahata, E.C. Lavelle, A.G. Coombes, and S.S. Davis The distribution of protein associated with poly(dl-lactide-co-glycolide) microparticles and its degradation in simulated body fluids J. Control. Release 50 1998 237 246
27. H. Sah A new strategy to determine the actual protein content of poly(lactide-co-glycolide) microspheres J. Pharm. Sci. 86 1997 1315 1318
28. F. Kang, G. Jiang, A. Hinderliter, P.P. DeLuca, and J. Singh Lysozyme stability in primary emulsion for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients Pharm. Res. 19 2002 629 633
29. A. Sanchez, B. Villamayor, Y. Guo, J. McIver, and M.J. Alonso Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co- glycolide) microspheres Int. J. Pharm. 185 1999 255 266
30. U. Bilati, C. Pasquarello, G.L. Corthals, D.F. Hochstrasser, E. Allémann, and E. Doelker Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for quantitation and molecular stability assessment of insulin entrapped within PLGA nanoparticles (in press) J. Pharm. Sci. 94 2005 1 7
31. M. van de Weert, R. van't Hof, J. van der Weerd, R.M. Heeren, G. Posthuma, W.E. Hennink, and D.J. Crommelin Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques J. Control. Release 68 2000 31 40
32. M.D. Blanco, and M.J. Alonso Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres Eur. J. Pharm. Biopharm. 43 1997 287 294
33. P. Johansen, H. Tamber, H.P. Merkle, and B. Gander Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs Eur. J. Pharm. Biopharm. 47 1999 193 201
34. K. Fu, K. Griebenow, L. Hsieh, A.M. Klibanov, and R. Langer FTIR characterization of the secondary structure of proteins encapsulated within PLGA microspheres J. Control. Release 58 1999 357 366
35. M. van de Weert, J. Hoechstetter, W.E. Hennink, and D.J. Crommelin The effect of a water/organic solvent interface on the structural stability of lysozyme J. Control. Release 68 2000 351 359
36. T.H. Yang, A. Dong, J. Meyer, O.L. Johnson, J.L. Cleland, and J.F. Carpenter Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres J. Pharm. Sci. 88 1999 161 165
37. C. Perez, P. De Jesus, and K. Griebenow Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co- glycolic) acid microspheres prepared by the water-in-oil-in-water method Int. J. Pharm. 248 2002 193 206
38. L. Jorgensen, C. Vermehren, S. Bjerregaard, and S. Froekjaer Secondary structure alterations in insulin and growth hormone water-in-oil emulsions Int. J. Pharm. 254 2003 7 10
39. D.H. Na, S.S. Lee, H.M. An, H.J. Kim, and K.C. Lee Maldi-Tof mass spectrometry for direct determination of the actual drug content in PLGA microspheres Proc. Int. Symp. Control. Rel. Bioact. Mater. 28 2001 956 957
40. D.H. Na, Y.S. Youn, S.D. Lee, M.W. Son, W.B. Kim, P.P. DeLuca, and K.C. Lee Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectometry J. Control. Release 92 2003 291 299
41. S. Sharif, and D.T. O'Hagan A comparison of alternative methods for determination of the levels of proteins entrapped in poly(lactide-co-glycolide) microparticles Int. J. Pharm. 115 1995 259 263
42. R.K. Gupta, A.C. Chang, P. Griffin, R. Rivera, Y.Y. Guo, and G.R. Siber Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid Vaccine 15 1997 672 678
43. P.G. Shao, and L.C. Bailey Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres Pharm. Dev. Technol. 4 1999 633 642
44. P. Johansen, Y. Men, R. Audran, G. Corradin, H.P. Merkle, and B. Gander Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives Pharm. Res. 15 1998 1103 1109
45. G. Zhu, and S.P. Schwendeman Influence of basic salts on stability and release of proteins in injectable poly(lactide-co-glycolide) delivery devices Proc. Int. Symp. Control. Rel. Bioact. Mater. 26 1999 1112 1113
46. G. Jiang, B.H. Woo, F. Kang, J. Singh, and P.P. DeLuca Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(d,l-lactdide-co-glycolide) microspheres J. Control. Release 79 2002 137 145
47. T.G. Park, H.Y. Lee, and Y.S. Nam A new preparation method for protein loaded poly(d,l-lactic-co-glycolic acid) microspheres and protein release mechanism study J. Control. Release 55 1998 181 191
48. Y.M. Kwon, M. Baudys, K. Knutson, and S.W. Kim In situ study of insulin aggregation induced by water-organic solvent interface Pharm. Res. 18 2001 1754 1759
49. D. Blanco, and M.J. Alonso Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants Eur. J. Pharm. Biopharm. 45 1998 285 294
50. S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang, and R. Langer Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres Pharm. Res. 8 1991 713 720
51. M.K. Yeh The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol J. Microencapsul. 17 2000 743 756
52. M. Morlock, H. Koll, G. Winter, and T. Kissel Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients, Eur. J. Pharm. Biopharm. 43 1997 29 36
53. C. Sturesson, and J. Carlfors Incorporation of protein in PLG-microspheres with retention of bioactivity J. Control. Release 67 2000 171 178
54. J.L. Cleland, and A.J. Jones Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres Pharm. Res. 13 1996 1464 1475
55. M.J. Alonso, R.K. Gupta, C. Min, G.R. Siber, and R. Langer Biodegradable microspheres as controlled-release tetanus toxoid delivery systems Vaccine 12 1994 299 306
56. M.F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron Preparation and characterization of protein C-loaded PLA nanoparticles J. Control. Release 60 1999 179 188
57. R. Ghaderi, and J. Carlfors Biological activity of lysozyme after entrapment in poly(d,l-lactide-co-glycolide)-microspheres Pharm. Res. 14 1997 1556 1562
58. J.-M. Péan, F. Boury, M.-C. Venier-Julienne, P. Menei, J.-E. Proust, and J.P. Benoit Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres? Pharm. Res. 16 1999 1294 1299
59. K.S. Suslick, D.A. Hammerton, and R.E. Cline The sonochemical hot spot J. Am. Chem. Soc. 108 1986 5641 5642
60. J.M. O'Shea, and J.H. Bradbury The effect of ultrasonic irradiation on proteins Aust. J. Biol. Sci. 26 1973 583 590
61. W.T. Coakley, R.C. Brown, and C.J. James The inactivation of enzymes by ultrasonic cavitation at 20 kHz Arch. Biochem. Biophys. 159 1973 722 729
62. S.E. Charm, and B.L. Wong Enzyme inactivation with shearing Biotechnol. Bioeng. 12 1970 1103 1109
63. S.E. Charm, and B.L. Wong Shear degradation of fibrinogen in the circulation Science 170 1970 466 468
64. S.E. Charm, and B.L. Wong Shear inactivation of heparin Biorheology 12 1975 275 278
65. L. Meinel, O.E. Illi, J. Zapf, M. Malfanti, M.H. Peter, and B. Gander Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres J. Control. Release 70 2001 193 202
66. U. Bilati, E. Allémann, and E. Doelker Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method Pharm. Dev. Technol. 8 2003 1 9
67. K. Griebenow, and A.M. Klibanov On protein denaturation in aqueous-organic mixtures but not in pure organic solvents J. Am. Chem. Soc. 118 1996 11695 11700
68. K.G. Carrasquillo, J.C. Carro, A. Alejandro, D.D. Toro, and K. Griebenow Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation J. Pharm. Pharmacol. 53 2001 115 120
69. K.G. Carrasquillo, A.M. Stanley, J.C. Aponte-Carro, P. De Jesus, H.R. Costantino, C.J. Bosques, and K. Griebenow Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein J. Control. Release 76 2001 199 208
70. H.R. Costantino, L. Firouzabadian, K. Hogeland, C. Wu, C. Beganski, K.G. Carrasquillo, M. Cordova, K. Griebenow, S.E. Zale, and M.A. Tracy Protein spray-freeze drying. Effect of atomization conditions on particle size and stability Pharm. Res. 17 2000 1374 1383
71. I.J. Castellanos, K.G. Carrasquillo, J.D. Lopez, M. Alvarez, and K. Griebenow Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique J. Pharm. Pharmacol. 53 2001 167 178
72. W. Jiang, and S.P. Schwendeman Stabilization of a model formalinized protein antigen encapsulated in poly(lactide-co-glycolide)-based microspheres J. Pharm. Sci. 90 2001 1558 1569
73. B. Gander, E. Wehrli, R. Alder, and H.P. Merkle Quality improvement of spray-dried, protein-loaded d,l-PLA microspheres by appropriate polymer solvent selection J. Microencapsul. 12 1995 83 97
74. F. Quaglia, G. De Rosa, E. Granata, F. Ungaro, E. Fattal, and M.I. La Rotonda Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying J. Control. Release 86 2003 267 278
75. B. Bittner, M. Morlock, H. Koll, G. Winter, and T. Kissel Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics Eur. J. Pharm. Biopharm. 45 1998 295 305
76. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima In vitro drug release behaviour of d,l-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method J. Pharm. Sci. 83 1994 727 732
77. O.L. Johnson, W. Jaworowicz, J.L. Cleland, L. Bailey, M. Charnis, E. Duenas, C. Wu, D. Shepard, S. Magil, T. Last, A.J. Jones, and S.D. Putney The stabilization and encapsulation of human growth hormone into biodegradable microspheres Pharm. Res. 14 1997 730 735
78. J.L. Cleland, E.T. Duenas, A. Park, A. Daugherty, J. Kahn, J. Kowalski, and A. Cuthbertson Development of poly(d,l-lactide-co-glycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis J. Control. Release 72 2001 13 24
79. X.M. Lam, E.T. Duenas, and J.L. Cleland Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres J. Pharm. Sci. 90 2001 1356 1365
80. G. Coppi, V. Iannuccelli, E. Leo, M.T. Bernabei, and R. Cameroni Protein immobilization in crosslinked alginate microparticles J. Microencapsul. 19 2002 37 44
81. D. Lemoine, F. Wauters, S. Bouchend'homme, and V. Préat Preparation and characterization of alginate microspheres containing a model antigen Int. J. Pharm. 176 1998 9 19
82. N. Elvassore, A. Bertucco, and P. Caliceti Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques J. Pharm. Sci. 90 2001 1628 1636
83. W. Leobandung, H. Ichikawa, Y. Fukumori, and N.A. Peppas Preparation of stable insulin-loaded nanospheres of poly(ethylene glycol) macromers and N-isopropyl acrylamide J. Control. Release 80 2002 357 363
84. W. Tiyaboonchai, J. Woiszwillo, R.C. Sims, and C.R. Middaugh Insulin containing polyethylenimine-dextran sulfate nanoparticles Int. J. Pharm. 255 2003 139 151
85. N. Wang, and X.S. Wu A novel approach to stabilization of protein drugs in poly(lactic-co-glycolic acid) microspheres using agarose hydrogel Int. J. Pharm. 166 1998 1 14
86. B.H. Woo, G. Jiang, Y.W. Jo, and P.P. DeLuca Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery Pharm. Res. 18 2001 1600 1606
87. M. Tobio, S.P. Schwendeman, Y. Guo, J. McIver, R. Langer, and M.J. Alonso Improved immunogenicity of a core-coated tetanus toxoid delivery system Vaccine 18 2000 618 622
88. R. Audran, Y. Men, P. Johansen, B. Gander, and G. Corradin Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents Pharm. Res. 15 1998 1111 1116
89. J. Brange, and L. Langkjaer Chemical stability of insulin. 3. Influence of excipients, formulation, and pH Acta Pharm. Nord. 4 1992 149 158
90. H. Sah Protein behaviour at the water/methylene chloride interface J. Pharm. Sci. 88 1999 1320 1325
91. Y. Tabata, S. Gutta, and R. Langer Controlled delivery systems for proteins using polyanhydride microspheres Pharm. Res. 10 1993 487 496
92. J.M. Harris, and F.M. Veronese Peptide and protein pegylation II - clinical evaluation Adv. Drug Del. Rev. 55 2003 1259 1260
93. M. Diwan, and T.G. Park Pegylation enhances protein stability during encapsulation in PLGA microspheres J. Control. Release 73 2001 233 244
94. G. Crotts, and T.G. Park Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles J. Control. Release 44 1997 123 134
95. M. Diwan, and T.G. Park Stabilization of recombinant interferon-α by pegylation for encapsulation in PLGA microspheres Int. J. Pharm. 252 2003 111 122
96. Y. Yamaguchi, M. Takenaga, A. Kitagawa, Y. Ogawa, Y. Mizushima, and R. Igarashi Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives J. Control. Release 81 2002 235 249
97. C.L. Stevenson Characterization of protein and peptide stability and solubility in non-aqueous solvents Curr. Pharm. Biotechnol. 1 2000 165 182
98. M.A. Winters, B.L. Knutson, P.G. Debenedetti, H.G. Sparks, T.M. Przybycien, C.L. Stevenson, and S.J. Prestrelski Precipitation of proteins in supercritical carbon dioxide J. Pharm. Sci. 85 1996 586 594
99. S.D. Yeo, P.G. Debenedetti, S.Y. Patro, and T.M. Przybycien Secondary structure characterization of microparticulate insulin powders J. Pharm. Sci. 83 1994 1651 1656
100. J.T. Chin, S.L. Wheeler, and A.M. Klibanov On protein solubility in organic solvents Biotechnol. Bioeng. 44 1994 140 145
101. S.J. Singer The properties of proteins in nonaqueous solvents Adv. Protein Chem. 17 1962 1 68
102. H.S. Yoo, H.K. Choi, and T.G. Park Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles J. Pharm. Sci. 90 2001 194 201
103. D. Quintanar-Guerrero, E. Allemann, H. Fessi, and E. Doelker Applications of the ion-pair concept to hydrophilic substances with special emphasis on peptides Pharm. Res. 14 1997 119 127
104. H.K. Kim, and T.G. Park Microencapsulation of dissociable human growth hormone aggregates within poly(d,l-lactic-co-glycolic acid) microparticles for sustained release Int. J. Pharm. 229 2001 107 116
105. A. Lucke, E. Fustella, J. Tessmar, A. Gazzaniga, and A. Göpferich The effect of poly(ethylene glycol)-poly(d,l-lactic acid) diblock copolymers on peptide acylation J. Control. Release 80 2002 157 168
106. M. Morlock, T. Kissel, Y.X. Li, H. Koll, and G. Winter Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties J. Control. Release 56 1998 105 115
107. T. Tsai, R.C. Mehta, and P.P. DeLuca Adsorption of peptides to poly(d,l-lactide-co-glycolide). 1. Effect of physical factors on the adsorption Int. J. Pharm. 127 1996 31 42
108. T. Tsai, R.C. Mehta, and P.P. DeLuca Adsorption of peptides to poly(d,l-lactide-co-glycolide). 2. Effect of solution properties on the adsorption Int. J. Pharm. 127 1996 43 52
109. J.W. Kostanski, B.C. Thanoo, and P.P. DeLuca Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release Orntide PLA and PLGA microspheres Pharm. Dev. Technol. 5 2000 585 596
110. M.M. Gasper, D. Blanco, M.E. Cruz, and M.J. Alonso Formulation of l-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release J. Control. Release 52 1998 53 62
111. S. Calis, R. Jeyanthi, T. Tsai, R.C. Mehta, and P.P. DeLuca Adsorption of salmon calcitonin to PLGA microspheres Pharm. Res. 12 1995 1072 1076
112. T. Jung, W. Kamm, A. Breitenbach, K.D. Hungerer, E. Hundt, and T. Kissel Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice Pharm. Res. 18 2001 352 360
113. W.J. Lin, L.I. Huang, and R.R. Chang Characterization of protein-loaded poly(ε-caprolactone) microparticles based on a factorial design J. Microencapsul. 18 2001 183 189
114. Y.P. Li, Y.Y. Pei, Z.H. Zhou, X.Y. Zhang, Z.H. Gu, J. Ding, J.J. Zhou, and X.J. Gao PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers J. Control. Release 71 2001 287 296
115. 2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres J. Control. Release 89 2003 71 85
116. G. De Rosa, R. Iommelli, M.I. La Rotonda, A. Miro, and F. Quaglia Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres J. Control. Release 69 2000 283 295
117. A. Sanchez, M. Tobio, L. Gonzalez, A. Fabra, and M.J. Alonso Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-α Eur. J. Pharm. Sci. 18 2003 221 229
118. A.C. Chang, and R.K. Gupta Stabilization of tetanus toxoid in poly(dl-lactic-co-glycolic acid) microspheres for the controlled release of antigen J. Pharm. Sci. 85 1996 129 132
119. I.J. Castellanos, R. Crespo, and K. Griebenow Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres J. Control. Release 88 2003 135 145
120. J.M. Pean, M.C. Venier-Julienne, F. Boury, P. Menei, B. Denizot, and J.P. Benoit NGF release from poly(d,l-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability J. Control. Release 56 1998 175 187
121. S. Takada, Y. Yamagata, M. Misaki, K. Taira, and T. Kurokawa Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique J. Control. Release 88 2003 229 242